Financial Data and Key Metrics Changes - The fourth quarter adjusted EBITDA margins improved to 17% from 16.6% in the third quarter and 15.8% in the fourth quarter of 2023, despite lower revenue quarter on quarter and year on year [6][5] - For the full year, the Completion Fluids and Products segment revenue was down 1%, but EBITDA grew by 2% year over year, with total revenue of $311 million, the second highest since 2015 [7][8] - The Industrial Chemicals business achieved record revenue and adjusted EBITDA for the fourth quarter, with a revenue growth of over 9% in 2024 compared to 2023, representing 22% of TETRA's total revenue [8][9] Business Line Data and Key Metrics Changes - The Water and Flowback segment achieved EBITDA margins of 13.8%, impacted by a year-end completion slowdown, with rig count and frac fleet count down more than double digits from last year [6][10] - The Industrial Chemicals segment is expected to ramp up meaningful volumes of zinc bromide-based electrolyte, contributing to future revenue growth [8][9] - The Water and Flowback Services segment is expected to maintain flat revenue in 2025 while increasing margins through operational efficiencies [11] Market Data and Key Metrics Changes - The company achieved a record volume of 89 million barrels of treated and recycled produced water for frac reuse in the fourth quarter [7] - The company is focusing on expanding its market presence in Northern Europe and the U.S., which provides stable markets with predictable revenue and earnings [9] Company Strategy and Development Direction - The company is making strategic investments in Brazil to support a large Deepwater Completion Fluids Award starting in Q2 2025, and is also increasing deepwater activity in the Gulf of America [9][10] - The company is prioritizing desalination solutions for produced water treatment and recycling, aiming to position itself as an industry leader in this area [11][12] - The company is exploring capital-efficient alternatives for its bromine project and lithium opportunities, focusing on cash flow generation and minimizing debt [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the U.S. business performance, driven by strong activity in the Gulf of America and the calcium chloride business [21] - The company projects net income before taxes between $19 million and $34 million and adjusted EBITDA between $55 million and $65 million for the first half of 2025, indicating a strong start to the year [14][24] - Management highlighted the importance of automation and desalination in improving margins and cash flow generation in the Water and Flowback segment [11][13] Other Important Information - The company eliminated the valuation allowance for deferred taxes, reflecting confidence in utilizing net operating loss carryforwards, potentially saving approximately $97.5 million in cash taxes [20][21] - The company reported cash on hand of $37 million and total liquidity of nearly $27 million as of December [26] Q&A Session Summary Question: Insights on growth opportunities for 2025 - Management indicated that the first half of 2025 will benefit from long-term projects, with expectations for increased volumes from Eos Energy and pilot operations in desalination [32][33] Question: Variances in EBITDA projections for the second half of 2025 - Management noted that while visibility is limited for the second half, they expect continued performance improvement driven by deepwater projects and electrolyte sales [38] Question: Capacity for pilot projects in desalination - Management confirmed high confidence in multiple pilot projects for 2025, with ongoing discussions and potential orders for additional pilot units [43][61] Question: Revenue recognition timeline for shipments to Eos - Revenue is recognized when the product leaves the facility, with a short timeframe for the product to be used in batteries [78] Question: Future structure of the company - Management anticipates a continued focus on industrial chemicals and deepwater services, with potential evolution of the water and flowback business towards desalination [75][76]

Tetra Technologies (TTI) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -25%. A quarter ago, it was expected that this oil and gas services company would post earnings of $0.03 per share when it actually produced earnings of $0.03, delivering no surprise.Over the last four quarters, ...

Financial Performance - Consolidated revenues for 2024 decreased by $27.151 million, or 4.3%, to $599.111 million compared to $626.262 million in 2023[206] - Gross profit decreased by $13.792 million, or 9.0%, resulting in a gross profit margin of 23.3% for 2024, down from 24.5% in 2023[206] - Income before discontinued operations increased significantly by $88.141 million, or 345.9%, to $113.620 million in 2024 compared to $25.479 million in 2023[206] - Net income attributable to TETRA stockholders rose by $82.500 million, or 320.0%, reaching $108.284 million in 2024, up from $25.784 million in 2023[206] - Adjusted EBITDA for 2024 was $99.4 million, representing 16.6% of total revenue, compared to $106.8 million and 17.1% in 2023, indicating a slight decline in profitability[227] - Total revenue for 2024 was $599.1 million, a decrease from $626.3 million in 2023, reflecting a challenging market environment[227] Division Performance - The Completion Fluids & Products Division reported revenues of $311.301 million, a slight decrease of $1.729 million, or 0.6%, from $313.030 million in 2023[214] - The Water & Flowback Services Division experienced a revenue decline of $25.422 million, or 8.1%, with total revenues of $287.810 million in 2024 compared to $313.232 million in 2023[217] Expenses and Costs - General and administrative expenses decreased by $6.621 million, or 6.9%, to $89.969 million in 2024 from $96.590 million in 2023[206] - Corporate overhead loss before taxes decreased by $7.5 million, or 10.3%, from $72.3 million in 2023 to $64.9 million in 2024, primarily due to an $8.3 million increase in unrealized gains on investments[222] - Operating cash flows decreased by $33.7 million, from $70.2 million in 2023 to $36.5 million in 2024, primarily due to decreased activity levels and changes in product mix[230] - General and administrative expenses decreased by $4.0 million, or 8.2%, primarily due to a $4.5 million reduction in salary-related expenses[222] Tax and Valuation - The effective tax rate for 2024 was (295.3)%, a significant change from 19.6% in 2023, primarily due to the reversal of the valuation allowance related to deferred tax assets[213] Strategic Investments and Projects - The company is focusing on strategic investments in TETRA CS Neptune fluids and water desalination projects to enhance near-term results[203] - A definitive feasibility study for bromine production was published in August 2024, with ongoing negotiations for bridging supply agreements to support future operations[202] - The company is negotiating bridging supply agreements for bromine, which may allow for flexibility in plant start-up timing and defer investments in Arkansas[232] Capital Expenditures and Liquidity - Total cash capital expenditures in 2024 were $60.7 million, with $23.4 million allocated to the Water & Flowback Services Division and $37.0 million to the Completion Fluids & Products Division[231] - Liquidity at the end of Q4 2024 was $182.2 million, consisting of $37.0 million in unrestricted cash and $145.2 million in available credit[228] - The company entered into a $265.0 million Term Credit Agreement in January 2024 to refinance prior debt and support the Arkansas bromine processing project[236] - A $5.5 million loss on debt extinguishment was recorded in 2024 due to non-cash unamortized finance costs related to the repayment of the previous Term Credit Agreement[222] Debt and Credit Facilities - The amended ABL Credit Agreement provides a senior secured revolving credit facility of up to $100.0 million with a $25.0 million accordion, maturing on May 13, 2029[238] - As of December 31, 2024, the company had no balance outstanding under the ABL Credit Agreement and $65.7 million available, increasing to $79.8 million as of February 25, 2025[239] - The Swedish Credit Facility has an availability of approximately $4.5 million as of December 31, 2024, with an interest rate of 2.95% per annum, expiring on December 31, 2025[240] - The Finland Credit Agreement had $1.4 million of letters of credit outstanding as of December 31, 2024, and has been renewed through January 31, 2026[241] - The New Term Credit Agreement consists of a $190.0 million funded term loan and a $75.0 million delayed-draw term loan, with a weighted average interest rate of 10.23%[256][257] Asset Management - The company sold its Kodiak shares for proceeds of $19.0 million in January 2025, net of transaction and broker fees[243] - As of December 31, 2024, the market value of equity holdings in Kodiak and Standard Lithium were $18.4 million and $1.2 million, respectively[243] - The company may consider divesting non-core assets and engaging in strategic transactions to enhance its business[244] Compliance and Risk - The company is in compliance with all covenants of its debt agreements as of December 31, 2024[242] - The company has currency exchange rate risk exposure related to revenues and expenses in foreign currencies, with no foreign currency exchange contracts outstanding as of December 31, 2024[258]

Exhibit 99.1 TETRA TECHNOLOGIES, INC. ANNOUNCES FOURTH QUARTER AND TOTAL YEAR 2024 RESULTS AND PROVIDES FIRST-HALF 2025 GUIDANCE Fourth Quarter Financial Highlights THE WOODLANDS, Texas, February 25, 2025 / PR Newswire / - TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced fourth quarter and total year 2024 results. Brady Murphy, TETRA's President and Chief Executive Officer, stated, "Our fourth quarter results were in-line with our expectations as strong offshore activity led by ...

Core Insights - TETRA Technologies, Inc. reported fourth quarter and total year 2024 results, highlighting a mixed performance with strong offshore activity but weaker U.S. onshore activity [1][2] - The company achieved an adjusted EBITDA margin of 17.0%, an improvement from previous quarters, despite a decrease in revenue [2][5] - TETRA's strategic focus on produced water led to record high treatment and recycling volumes, alongside the successful commercial launch of the TETRA Oasis Total Desalination Solution [2][8] Financial Performance - Fourth quarter 2024 revenue was $135 million, a decrease of 5% from the third quarter [5][16] - Net income from continuing operations was $102 million, significantly higher than $2.8 million in the previous quarter, largely due to non-recurring tax credits [5][10] - Adjusted EBITDA for the fourth quarter was $22.8 million, down 3% from the third quarter, with margins impacted by lower production volumes [6][9] Cash Flow and Investments - Cash flow from operating activities was $5.6 million, a decline from $19.9 million in the third quarter [7][10] - The company reported an adjusted free cash flow use of $9.3 million in the fourth quarter, compared to a positive $6.3 million in the third quarter [7][10] - TETRA monetized its equity investment in Kodiak Gas Services, generating approximately $19 million in cash proceeds [2][6] Strategic Initiatives - TETRA invested $22 million in strategic initiatives in Arkansas, focusing on engineering and reservoir studies for a bromine project [10][11] - The company anticipates a strong first half of 2025, with expected net income before taxes between $19 million and $34 million [3][12] - TETRA is prioritizing projects that can impact near-term results, including TETRA CS Neptune fluids and water desalination technologies [12][11] Tax and Deferred Assets - A favorable adjustment of $97.5 million to deferred tax assets was recognized, reflecting TETRA's profitable position and expectations of stronger future profits [4][15] - The company estimates that its U.S. federal tax loss carryforward can offset approximately $345 million of taxable pretax income in 2025 and beyond [4][15] Yearly Overview - Total year revenue for 2024 was $599 million, a decrease of $27 million from 2023, with international operations contributing to the decline [16][17] - Income from continuing operations improved to $113.6 million in 2024, compared to $25.5 million in 2023 [16][17] - Adjusted EBITDA for the full year was $99 million, down from $107 million in 2023, with margins decreasing slightly [16][17]

Core Viewpoint - Thiogenesis Therapeutics, Corp. has entered into a consulting and investor relations agreement with Bull Markets Media GmbH to enhance its shareholder base and expand its network in Europe [1][2]. Group 1: Agreement Details - The consulting fee for the agreement is C$60,000, with 50% payable upon signing and the remainder due on June 1, 2025 [3]. - The agreement includes the grant of 100,000 stock options to the consultant, allowing the acquisition of shares at $0.64 each for a term of 3 years, with options vesting in tranches [3]. - The agreement has a duration of twelve months and can be renewed annually for up to two additional years [3]. Group 2: Company Overview - Thiogenesis Therapeutics is a clinical-stage biopharmaceutical company focused on developing sulfur-containing prodrugs aimed at treating serious pediatric diseases with unmet medical needs [5]. - The company utilizes a streamlined 505 (b)(2) regulatory pathway in the US and a hybrid system in Europe for regulatory submissions, which allows for the use of existing safety data [5]. - Initial target indications for the company's products include Mitochondrial Encephalopathy Lactic Acidosis and Stroke (MELAS), Leigh syndrome, Rett syndrome, and pediatric MASH [5]. Group 3: Regulatory and Compliance - The agreement with the consultant is subject to acceptance by the TSX Venture Exchange [4]. - The company has received final acceptance from the TSXV for its investor relations contract with Triomphe Holdings Ltd. [4].

Company Overview - Thiogenesis Therapeutics, Corp. is a clinical-stage biotechnology company focused on developing disulfides that enhance the production of intracellular antioxidants and therapeutic compounds [1][5] - The company operates through its wholly owned subsidiary based in San Diego, California, and is listed on both the TSX Venture Exchange under the symbol TTI and the OTCQX Best Market under the symbol TTIPF [1][5] Market Activity - Thiogenesis' common shares are now trading on the OTCQX Best Market, which is the highest-level market of OTC Markets, enhancing visibility and accessibility to U.S. investors [1] - The company has achieved Depository Trust Company (DTC) eligibility status, allowing for electronic settlement of its common shares, which facilitates trading for U.S. investors [2] Clinical Development - On January 27, 2025, Thiogenesis announced it received final regulatory clearance to initiate a Phase 2 clinical trial in Europe for the treatment of Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like episodes (MELAS) [3] - The company is targeting serious pediatric diseases with unmet medical needs, including MELAS, Leigh's syndrome, Rett syndrome, and pediatric MASH [5] Disease Background - MELAS is a rare inherited mitochondrial disorder often caused by a mutation in the MT-TL1 gene, with initial symptoms including seizures, vomiting, and muscle weakness [4] - The disease typically presents before the age of 20 and has no approved drugs, making it a viable target for Thiogenesis' therapeutic development [4]

Core Viewpoint - TETRA Technologies, Inc. will release its fourth quarter and full year 2024 results on February 25, 2025, followed by a conference call on February 26, 2025, to discuss these results [1] Company Overview - TETRA Technologies, Inc. is an energy services and solutions company focused on environmentally conscious services and solutions [3] - The company operates on six continents and has a portfolio that includes Energy Services, Industrial Chemicals, and Critical Minerals [3] - TETRA provides products and services to the oil and gas industry and calcium chloride for various applications, while also expanding into the low-carbon energy market [3] - The company aims to meet the demand for sustainable energy in the twenty-first century through its chemistry expertise, key mineral acreage, and global infrastructure [3]

Company Overview - TETRA Technologies, Inc. is an energy services and solutions company focused on developing environmentally conscious services and solutions that enhance quality of life [3] - The company operates on six continents and has a portfolio that includes Energy Services, Industrial Chemicals, and Critical Minerals [3] - TETRA provides products and services to the oil and gas industry and calcium chloride for various applications, while also expanding into the low-carbon energy market [3] - The company leverages its chemistry expertise, key mineral acreage, and global infrastructure to meet the demand for sustainable energy in the 21st century [3] Upcoming Events - TETRA's senior management will participate in the 27th Annual Needham Growth Conference in New York on January 14th and 15th, 2025 [1] - CEO Brady Murphy and CFO Elijio Serrano will host one-on-one meetings and present on January 14 from 8:45 A.M. to 9:25 A.M. (ET) [2] - The presentation will be webcast, and interested parties can register for one-on-one meetings at the Lotte New York Palace Hotel [2]

Market Overview - The global power tools market is projected to grow at a CAGR of 6.36% from 2023 to 2029 [2] - The estimated market value in 2023 is $40 billion, with a forecasted value of $57.9 billion by 2029 [22] Regional Insights - APAC held the largest share of the global power tools market, accounting for over 36% in 2023 [16] - China and India are significant drivers of growth in the construction industry due to rapid urbanization and industrialization [3][4] Adoption Trends - The adoption of power tools is increasing across various industries due to their productivity, precision, and efficiency benefits [5] - The rise in DIY projects and home improvement activities is boosting the power tools market, particularly in developed and developing economies [6][9] Market Segmentation - By operation type, the cutting segment is expected to be the largest revenue segment [10] - The drilling and fastening tools segment held the largest share of the global power tools market in 2023 [12] - The electric-powered segment dominates the market, with significant growth projected due to innovations in battery technology [13] Competitive Landscape - The market is moderately fragmented, with key players including Stanley Black & Decker, Bosch Power Tools, and TTI [19] - Bosch Power Tools leads through technological advancements, while local vendors compete in this dynamic landscape [19] Key Questions Addressed - The report addresses key questions regarding market dominance, size, growth rate, trends, and key players in the global power tools market [21]